Across TCGA pan-cancer cohorts, MIR99B Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated MIR99B data layer compared with 16 for mass-spec protein.

The strongest signal is observed in mesothelioma (MESO), where higher MIR99B Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MIR99B expression acts as an unfavorable survival marker.

MESO are the cancer types where MIR99B Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Median	All	0.018	0.559	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: MIR99B tumor-vs-normal RNA expression · all MIR99B data types